Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 14,045.24 Crore) operating in Pharmaceuticals sector. Granules India Ltd. key Products/Revenue ...
Jan 13, 2025 11:16 Lupin Gets USFDA Approval for Generic Cystic Fibrosis Treatment Lupin receives USFDA approval for its generic version of Ivacaftor oral granules, a treatment for cystic fibrosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback